The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors (NCT06938555) | Clinical Trial Compass
RecruitingNot Applicable
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
United States60 participantsStarted 2025-03-18
Plain-language summary
The investigators are interested in finding out how Prolonged Nightly Fasting (PNF) and/or health education may impact health and cancer recovery for breast cancer patients and survivors.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. ≥18 years old
✓. diagnosed with breast cancer (all stages included)
✓. ≥3 months post neoadjuvant or adjuvant chemotherapy (maintenance or palliative systemic therapy is included)
✓. score ≤30 or lower on the Patient Reported Outcome Measurement Information System Cognitive Function Short Form 8a (sr-CRCI)
✓. able to speak/understand English
✓. have access to a computer and Wi-Fi
✓. live within the United States
✓. Identifies as female
Exclusion criteria
✕. type 1 diabetes
✕. actively enrolled in formal diet/weight loss program
✕. previous bariatric surgery
✕. eating disorder history
✕. night shift work
✕. pregnant, breast feeding, or trying to get pregnant
✕. dementia, psychological, psychiatric, or neurological diagnoses
What they're measuring
1
Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.
Timeframe: Baseline (T1) and 8-week end point (T2) data collection
2
Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.
Timeframe: Baseline (T1) and 8-week end point (T2) data collection